Healthequity Inc (HQY)

Currency in USD
88.46
+1.21(+1.39%)
Closed·
88.460.00(0.00%)
·
HQY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
86.3689.12
52 wk Range
72.76107.62
Key Statistics
Prev. Close
87.25
Open
87.19
Day's Range
86.36-89.12
52 wk Range
72.76-107.62
Volume
860.37K
Average Volume (3m)
842.33K
1-Year Change
-6.6582%
Book Value / Share
23.8
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HQY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
119.33
Upside
+34.90%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Healthequity Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Analyst Ratings

15 Buy
0 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 119.33
(+34.90% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy115.00+30.00%110.00MaintainSep 18, 2026
Raymond James
Buy115.00+30.00%-MaintainSep 03, 2026
Citizens
Buy111.00+25.48%-MaintainAug 28, 2026
RBC Capital
Buy108.00+22.09%-MaintainJun 03, 2026
Citizens
Buy111.00+25.48%110.00MaintainJun 01, 2026

Healthequity Inc SWOT Analysis


HSA Market Leade
Explore HealthEquity's dominant position in the HSA sector, leveraging technology to capture a significant share of the growing health savings market
Financial Performance
Delve into HealthEquity's impressive 19% YoY revenue growth, reaching $311.8 million in Q4 FY2025, despite operational challenges and fraud-related costs
Growth Catalysts
Learn about potential regulatory changes that could expand HealthEquity's market by 40-45 million U.S. households, driving future growth opportunities
Analyst Outlook
Discover why analysts maintain a strong consensus recommendation, with price targets ranging from $100 to $115, despite recent operational headwinds
Read full SWOT analysis

Healthequity Inc Earnings Call Summary for Q2/2027

  • HealthEquity Q2 FY2027 EPS of $1.24 beat estimates by 4.2%; revenue rose 8% YoY to $350.73M, topping forecasts by 0.43%.
  • Adjusted EBITDA climbed 11% to record $167M with margin expanding to 48%; gross margin improved to 74% from 71% year-earlier.
  • Company raised FY2027 guidance to revenue of $1.411B-$1.421B and EPS of $4.66-$4.73, citing efficiency gains and strong H1 results.
  • HSA accounts grew 8% to 10.7M; new HSAs from sales surged 24% as healthcare affordability pressures drive adoption of high-deductible plans.
  • Shares plunged 13.6% to $90.23 despite beat, signaling investor concern over growth pace, valuation, or modest guidance raise magnitude.
Last Updated: 2026-08-27, 09:58 a/m
Read Full Transcript

Earnings

Latest Release
Aug 27, 2026
EPS / Forecast
1.24 / 1.19
Revenue / Forecast
350.73M / 349.22M
EPS Revisions
Last 90 days

HQY Income Statement

Compare HQY to Peers and Sector

Metrics to compare
HQY
Peers
Sector
Relationship
P/E Ratio
30.9x36.5x−0.4x
PEG Ratio
0.450.260.00
Price/Book
3.7x3.8x2.6x
Price / LTM Sales
5.4x2.7x3.1x
Upside (Analyst Target)
35.2%18.0%54.8%
Fair Value Upside
Unlock0.2%7.6%Unlock

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Employees
2814

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
49.33M59.63%4.36B
Other Institutional Investors
42.26M40.37%3.74B
Public Companies & Retail Investors
0.000.00%0.00
Total
91.59M100.00%8.1B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.63%11,277,914997,419
Wasatch Advisors LP9.62%7,960,735704,047

People Also Watch

65.83
TTAN
+3.64%
227.00
ARW
-1.40%
37.19
XENE
-0.16%
127.56
SAIC
-0.51%
227.83
ASND
-0.11%

FAQ

What Is the Healthequity Inc (HQY) Stock Price Today?

The Healthequity Inc stock price today is 88.46 USD.

What Stock Exchange Does Healthequity Inc Trade On?

Healthequity Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Healthequity Inc?

The stock symbol for Healthequity Inc is "HQY."

What Is the Healthequity Inc Market Cap?

As of today, Healthequity Inc market cap is 7.35B USD.

What Is Healthequity Inc's Earnings Per Share (TTM)?

The Healthequity Inc EPS (TTM) is 2.76.

When Is the Next Healthequity Inc Earnings Date?

Healthequity Inc will release its next earnings report on Dec 08, 2026.

From a Technical Analysis Perspective, Is HQY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Healthequity Inc Stock Split?

Healthequity Inc has split 0 times.

How Many Employees Does Healthequity Inc Have?

Healthequity Inc has 2814 employees.

What is the current trading status of Healthequity Inc (HQY)?

As of Sep 30, 2026, Healthequity Inc (HQY) is trading at a price of 88.46 USD, with a previous close of 87.25 USD. The stock has fluctuated within a day range of 86.36 USD to 89.12 USD, while its 52-week range spans from 72.76 USD to 107.62 USD.

What Is Healthequity Inc (HQY) Price Target According to Analysts?

The average 12-month price target for Healthequity Inc is 119.33 USD, with a high estimate of 142 USD and a low estimate of 105 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.